++++ First Issue: Summer 2017 ++++
European Pharmaceutical Law Review - EPLR
The European Pharmaceutical Law Review (EPLR) reports on key legislative developments in the EU and the Member States, and identifies and analyses important judgments that shape the interpretation and application of EU pharmaceutical law, in particular those by the European Courts, international courts and tribunals such as the WTO's Dispute Settlement Body, and higher national courts.
In order to establish itself as a forum for dialogue between different stakeholders in pharmaceutical regulation and governance, it will invite contributions from academics, practitioners, regulators and civil society representatives.
Topics covered by EPLR include:
• pharmaceutical law and policy in all jurisdictions (regional, national, international);
• Commission decisions (EMA opinions) and regulatory guidelines;
• national, EU, and international jurisprudence;
• medical devices;
• borderline cases: pharmaceuticals/food/cosmetics/chemicals
• patents /trademarks;
• health technology assessment and pricing/reimbursement;
• digital health/big data;
All contributions will be subject to double blind peer-review before acceptance for publication and are required to conform to the author guidelines available at: www.lexxion.eu/core/author-guidelines.
EPLR's Target Audience
The quarterly addresses everyone who is concerned with pharmaceutical law and policy issues such as academics (in the field of law, pharmacists, and other relevant research fields), legal practitioners in national and international law firms, government officials working in EU public administration, judges and legal experts in domestic, European and international courts, consultancies, business people in the EU and beyond as well as stakeholder organisations representing professionals, patients, and civil society.
Each issue of EPLR will be a balanced mixture of original research articles, first-hand country or thematic policy reports, timely case annotations on important ECJ/GC rulings and other international/national court judgments, book reviews as well as other information material and updates, including opinions, case summaries or event reports.
You want to know more about EPLR?